Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Receivables: 2015-2022

Historic Receivables for HUTCHMED (China) (HCM) over the last 8 years, with Dec 2022 value amounting to $151.2 million.

  • HUTCHMED (China)'s Receivables fell 1.84% to $168.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $649.8 million, marking a year-over-year increase of 2.91%. This contributed to the annual value of $151.2 million for FY2022, which is 8.15% down from last year.
  • Per HUTCHMED (China)'s latest filing, its Receivables stood at $151.2 million for FY2022, which was down 8.15% from $164.6 million recorded in FY2021.
  • HUTCHMED (China)'s Receivables' 5-year high stood at $164.6 million during FY2021, with a 5-year trough of $53.7 million in FY2018.
  • In the last 3 years, HUTCHMED (China)'s Receivables had a median value of $151.2 million in 2022 and averaged $130.5 million.
  • As far as peak fluctuations go, HUTCHMED (China)'s Receivables spiked by 117.18% in 2021, and later fell by 8.15% in 2022.
  • Over the past 5 years, HUTCHMED (China)'s Receivables (Yearly) stood at $53.7 million in 2018, then climbed by 23.11% to $66.0 million in 2019, then increased by 14.76% to $75.8 million in 2020, then skyrocketed by 117.18% to $164.6 million in 2021, then dropped by 8.15% to $151.2 million in 2022.